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Phenazine-type metabolites arise from either phena-
zine-1-carboxylic acid (PCA) or phenazine-1,6-dicar-
boxylic acid (PDC). Although the biosynthesis of
PCA has been studied extensively, PDC assembly
remains unclear. Esmeraldins and saphenamycin,
the PDC originated products, are antimicrobial and
antitumor metabolites isolated from Streptomyces
antibioticus Tu¨ 2706. Herein, the esmeraldin biosyn-
thetic gene cluster was identified on a dispensable
giant plasmid. Twenty-four putative esm genes
were characterized by bioinformatics, mutagenesis,
genetic complementation, and functional protein
expressions. Unlike enzymes involved in PCA bio-
synthesis, EsmA1 and EsmA2 together decisively
promoted the PDC yield. The resulting PDC under-
went a series of conversions to give 6-acetylphena-
zine-1-carboxylic acid, saphenic acid, and saphena-
mycin through a unique one-carbon extension by
EsmB1–B5, a keto reduction by EsmC, and an
esterification by EsmD1–D3, the atypical polyketide
sythases, respectively. Two transcriptional regula-
tors, EsmT1 and EsmT2, are required for esmeraldin
production.
INTRODUCTION
The esmeraldins are a group of green diphenazine metabolites
isolated from Streptomyces antibioticus Tu¨ 2706 (Keller-
Schierlein et al., 1988) (Figure 1). Phenazines feature a planar
core structure of three six-membered aromatic rings, with the
middle one containing two nitrogen atoms in a 5,10-diaza-
anthracene arrangement (Mentel et al., 2009). Besides esmeral-
dins A and B, this strain also accumulates several esmeraldin
precursors including phenazine-1,6-dicarboxylic acid (PDC),
6-acetyl-phenazine-1-carboxylic acid (6-acetyl-PCA), saphenic
acid, saphenyl esters, and saphenamycin, along with a side
product, phenazine-1-carboxylic acid (PCA) (Geiger et al.,
1988) (Figure 1; Table S1 available online). Esmeraldin B exhibits1116 Chemistry & Biology 19, 1116–1125, September 21, 2012 ª201an antitumor effect, while saphenamycin, also found in
Streptomyces canaries MG314-hF8, displays a broad range of
biological activities including antibacterial, antitumor, and
mosquito larvacidal activities (Geiger et al., 1988; Kitahara
et al., 1982; Laursen and Nielsen, 2004). Saphenic acid is
a common pharmacophore for many antibiotics and antitumor
reagents including DC-86-M and phenazostatins, which were
isolated from S. luteogriseus and Streptomyces sp. 833, respec-
tively (Laursen and Nielsen, 2004). The actions of phenazine
products, mainly attributed to redox activity, are implicated in
the virulence and competitive fitness of the producing organ-
isms. Besides a wide range of bioactivities, phenazines can pro-
mote iron uptake by reducing ferric minerals to a more soluble
ferrous form (Hernandez et al., 2004; Mentel et al., 2009).
Recently, a well-known phenazine metabolite, pyocyanin, was
also found to activate the transcriptional regulator SoxR, which
triggers the expression of genes involved in the oxidative stress
response and the trafficking of small molecules to cope with
environmental changes (Dietrich et al., 2008).
Phenazine metabolites are divided into two categories ac-
cording to the biosynthetic origins, PCA or PDC, which do not
interconvert in the producers (McDonald et al., 2001). As PCA
and PDC have been proposed to arise from a common sym-
metrical precursor, hexahydrophenazine-1,6-dicarboxylic acid
(hexahydro-PDC-1), the foremost issue in phenazine biosyn-
thesis is how the enzyme(s) leads to the PDC versus PCA
assembly. To date, only a single set of genes, ehpA-E, has
been confirmed to govern the PDC biosynthesis in Erwinia
herbicola Eh1087 (Giddens et al., 2002), compared with 90
gene clusters found to be involved in the synthesis of PCA-
or PCA-related products in many microorganisms (Mavrodi
et al., 2010). So far, the corresponding PCA-forming enzymes,
PhzA-G, have been extensively studied (Mentel et al., 2009),
whereas the process for PDC formation remains to be clarified.
Feeding experiments showed that esmeraldins arise from
PDC, which undergoes sequential reactions to form 6-acetyl-
PCA, saphenic acid, and saphenamycin, followed by a dimeriza-
tion event to give the esmeraldins (McDonald et al., 1999; Van’t
Land et al., 1993). Labeled acetate was incorporated into the
methyl groups of 6-acetyl-PCA and the downstream products,
suggesting that a polyketide extension with further decarboxyl-
ation is involved in the PDC conversion to form 6-acetyl-PCA.
The incorporation of 6-acetyl-PCA into saphenic acid and2 Elsevier Ltd All rights reserved
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Figure 1. Phenazine Metabolites Isolated from S. antibioticus
Tu¨ 2706
(A) Chemical structures of esmeraldins, saphenyl metabolites, PDC, and PCA.
(B) The green esmeraldin pigments are produced by the wild-type strain of
S. antibioticus Tu¨ 2706, which is plated onMS agar medium at 28C for 7 days.
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Saphenamycin and Esmeraldin Biosynthesisesmeraldins showed that the keto group of 6-acetyl-PCA is con-
verted into an alcohol to give saphenic acid, likely by a reductase.
Notably, saphenamycin and other saphenyl esters contain
a characteristic ester bond that links the saphenic acid core
with a 6-methylsalicyl group or a fatty acyl chain, respectively.
Feeding experiments suggest that one half of molecule of esmer-
aldins B or Amay originate from saphenamycin or other saphenyl
esters, while the other half could be derived from saphenic acid.
It is important to note that S. antibioticus Tu¨ 2706 tends to
permanently lose the ability to produce esmeraldins (Van’t
Land et al., 1993), and the incompetence to sustain the esmeral-
din production may be attributed to instability of the biosynthetic
genes, which adds to the complexity of their molecular genetic
investigation. Herein, we report the identification of an esmeral-
din biosynthetic gene cluster on a giant plasmid carried by
S. antibioticus Tu¨ 2706, the characterization of 24 putative esm
genes by bioinformatics, mutagenesis, genetic complementa-
tion, and functional protein expressions in Escherichia coli.
RESULTS
Cloning and Identification of the Esmeraldin
Biosynthetic Gene Cluster
To clone the esmeraldin biosynthetic genes, we screened a
cosmid library of S. antibioticus Tu¨ 2706 with the phzA-G probe
from the PCA producerPseudomonas fluorescens 2-79 (Mavrodi
et al., 1998). Three cosmid clones, 6B10, 3E11, and 11E12, were
identified and mapped to share an overlapping region located in
the 23.5 kb BglII fragment (Figure 2A).
To verify that the cloned cosmids contain the genes involved in
the biosynthesis of esmeraldin, we deleted the internal 29.9 kb
BglII fragments of cosmid 3E11 to create 3E11-D, which was
introduced into S. antibioticus Tu¨ 2706 via conjugation. ToChemistry & Biology 19, 1116–112remove the internal 29.9 kb BglII genomic region of the wild-type
strain through a double-crossover homologous recombination,
we screened the nonpigmented apramycin-sensitive colonies
after multiple subcultures. Among 300 candidate colonies, only
one, LSB017, was confirmed to carry an expected internal dele-
tion equivalent to 3E11-D by Southern blot analysis (Figure 2B).
High-performance liquid chromatography (HPLC) analysis of
LSB017 failed to detect either esmeraldins or any other phena-
zine metabolite, but esmeraldin production by LSB017 can be
restored upon the introduction of 3E11 (Figure 3). Interestingly,
Southern blots using the 3E11 probe did not reveal a signal for
the rest of the nonpigmented apramycin-sensitive mutants
(Figure S1). Pulsed-field gel electrophoresis further indicated
that a 550 kb HpaI fragment carrying the cloned esm genes is
located in a giant plasmid, which was fully eliminated from the
genome of these nonpigmentedmutants (Figure S1). This obser-
vation could explain the frequent irretrievable loss of esmeraldin
production during culture (Van’t Land et al., 1993). Unlike
LSB017 that can be transformed with 3E11 to produce esmeral-
dins, these nonpigmented mutants were no longer capable of
sustaining 3E11 introduced by conjugation. A similar phenom-
enon was also observed in attempts to transform Streptomyces
lividans with 3E11, which exclusively degenerated into smaller
plasmids under the apramycin selection. These results suggest
that the putative esmeraldin-related resistance gene is not
included in the cloned esm cluster and could reside elsewhere
on the lost 550 kb fragment.
Single-Gene-Disrupted Mutation and Genetic
Complementation
The nucleotide sequence of the internal 29.9 kb region of 3E11
revealed 25 open reading frames, tentatively assigned as the
esm genes (GenBank ID code JF417969) (Table 1; Figure 2A).
As it requires extensive effort to perform genomic mutations
due to the instability of the esm genesmentioned above, we con-
structed a series of 3E11 derivatives with EZ-Tn5 insertions,
which were mapped within the cluster as outlined in Figure S2.
To ensure the functional expression of the genes downstream
of the inserted target, we preferred to select 3E11 derivatives
containing the transposon insertion in the same orientation as
the disrupted gene. These 3E11 derivatives were then intro-
duced into LSB017 by conjugation to yield the equivalent trans-
formants that resembled the single-gene-disrupted mutants.
Herein, we refer to these transformants as the corresponding
gene-disrupted mutants. In addition to a group of mutants that
accumulated green esmeraldins, we also obtained nonpig-
mented mutants and mutants that produced novel pigments.
To match the functions of the esm genes to steps in esmeral-
din biosynthesis, we performed a series of genetic complemen-
tation experiments on the non-esmeraldin producing mutants,
which were consequently classified into four major groups,
esmA, B, C, and D. The esmA1 and esmA2 mutants secreted
dark red pigments, while the esmA3–A5 mutants produced no
pigments. The esmB, esmC, and esmD groupmutants displayed
light brown, dark brown, and yellow colors, respectively. To
conduct genetic complementations, the esmA1–A5 mutants
and esmB group mutants were cultured side by side on agar
plates. The green esmeraldin pigments appeared on the border
area of the esmA mutants rather than the esmB mutants,5, September 21, 2012 ª2012 Elsevier Ltd All rights reserved 1117
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Figure 2. Genetic Organization of the esm Genes
(A) The key regulatory genes are colored in yellow, while the esmA-D group genes are shown in blue, red, orange, and green, respectively. Bold lines represent the
overlapping cosmids, 6B10, 11E12, and 3E11, where the BglII restriction sites are indicated.
(B) Southern analysis of the wild-type (left lane) and LSB017 (right lane) genomic DNAs digested with BglII and probed with 3E11.
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Saphenamycin and Esmeraldin Biosynthesisindicating that the EsmA1–A5 proteins catalyze the upstream
reactions and provide the proper substrate for the proteins of
the EsmBgroup. Likewise, the EsmB1–B5 proteins function prior
to the EsmC, followed by the action of the EsmD group enzymes.
Mutants assigned in the same group, e.g., the esmB1–B5
mutants, could not complement each other to produce esmeral-
dins, suggesting highly associated activities of the EsmB group
enzymes.
PDC Assembly by EsmA1–A8
The esmA6,A7, andA8 genes, which are likely to share the same
transcription unit, encode a 3-deoxy-D-arabino-heptulosonate
7-phosphate (DAHP) synthase, shikimate kinase, and choris-
mate synthase, respectively, all commonly involved in aromatic
amino acid biosynthesis (Dias et al., 2006; Hartmann et al.,
2006; Webby et al., 2005). The three esmA6–A8 mutants main-
tained a large amount of esmeraldin production similarly to the
wild-type strain, suggesting that the activity of the correspond-
ing housekeeping enzymes compensated their deficiencies.
As phenazine biosynthesis requires chorismate as substrate
(McDonald et al., 2001), the presence of EsmA6–A8 could secure
the chorismate supply for the subsequent reactions. EsmA4, A5,
and A3, homologs, corresponding to PhzE, PhzD, and PhzF,
are likely to catalyze the sequential formation of 2-amino-2-
desoxyisochorismic acid (ADIC), trans-2,3-dihydro-3-hydrox-
yanthranilic acid (DHHA), and 6-amino-5-oxocyclohex-2-ene-
1-carboxylic acid (AOCHC) (Blankenfeldt et al., 2004; McDonald
et al., 2001; Parsons et al., 2003). The colorless esmA3–A5
mutants failed to produce esmeraldin or any other phenazine
metabolite, indicating the essentiality of esmA3, A4 and A5 in
the assembly of the precursor phenazines. EsmA1 resembles
the PhzA/B enzymes that facilitate double imine formation to
give a tricyclic ring, while EsmA2 is similar to PhzG, which could
be involved in the oxidation of the nascent tricyclic product to
yield PCA (Ahuja et al., 2008; Parsons et al., 2004). Interestingly,
both the esmA1 mutant and the esmA2 mutant accumulated
more than 2.5-fold of the shunt product PCA than the LSB017
strain carrying 3E11 (Figure 3). While the esmA1mutant retained
production of a substantial amount of saphenamycin and green
pigment esmeraldins, the PDC-derived metabolites were barely
detectable in the esmA2 mutant.1118 Chemistry & Biology 19, 1116–1125, September 21, 2012 ª201To investigate the catalytic roles of EsmA1 and EsmA2 in PDC
formation, we cloned esmA1 and esmA2 in an expression vector,
pRSETB.We also amplified phzC-F operon excluding phzG from
the previously constructed pT7-6CDEFG (Mavrodi et al., 1998)
and inserted into the expression vector, pET-30 Xa/LIC. Coex-
pression of EsmA1 and PhzC-F in E. coli BL21 DE3 (plysS)
increased PDC production by 20-fold compared with the one
only expressing PhzC-F (Figure 4). Presence of EsmA1 also
increased the productions of PCA and phenazine by 4- and
2-fold, respectively, indicating EsmA1 nonspecifically promoted
the productions of all phenazine-type metabolites. When EsmA2
was coexpressed with PhzC-F, the PDC level was boosted by
20-fold, which is similar to the coexpression result of PhzG and
PhzC-F.
To study the collaborative activities of EsmA1 and A2,
we coexpressed both EsmA1/EsmA2 with PhzC-F in E. coli.
Notably, this increased the PDC yield by around 150-fold
compared with the strain expressing PhzC-F (Figure 4). Only
4.8-fold PCA was accumulated, in contrast to a predominant
26-fold PCA production by the strain containing a full set of
PhzAB/PhzG/PhzCDEF (PhzA-G). This dramatic difference indi-
cated the catalytic preference of EsmA1/A2 and PhzAB/G
toward the formation of PDC and PCA, respectively. We further
created strains containing hybrid combinations of PhzAB/
EsmA2/PhzC-F and EsmA1/PhzG/PhzC-F, which only produced
7% and 22% PDC, respectively, in comparison with the strain
expressing EsmA1/EsmA2/PhzC-F, suggesting a stringent
catalytic cooperation of EsmA1 and EsmA2.
A Unique, One-Carbon Extension by EsmB1–B5
Followed with a Keto Reduction by EsmC
Methyl-labeled acetates were incorporated into the appended
methyl group of 6-acetyl-PCA, suggesting a unique one-step
polyketide synthase (PKS) extension of the carboxylic group of
PDC, immediately followed by a decarboxylation to give a
6-acetyl group (McDonald et al., 1999). Two groups of polyketide
biosynthetic genes, esmB3–B5 and esmD1–D3, were found
in the esm cluster. Sequence analysis further revealed that
EsmB4 contains polyketide synthase domains, b-ketoacyl-
ACP-synthase (KS), malonyl transferase (AT), and acyl
carrier protein (ACP), suggesting that EsmB4 catalyzes the2 Elsevier Ltd All rights reserved
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Figure 3. HPLC Analysis of the Crude Extracts from Various S. antibioticus Tu¨ 2706 Strains
(A) The wild-type strain.
(B) The LSB017 mutant.
(C) The LSB017 mutant carrying 3E11.
(D) The esmA1 mutant.
(E) The esmA2 mutants.
(F–J) The esmB1–B5 mutants.
(K) The esmC mutant.
(L–N) The esmD1–D3 mutants.
The crude extracts from 6 day cultures were injected at 40 ml scale for each analysis. The dashed lines indicate the peaks of related phenazine metabolites. The y
axis indicates the relative abundance (absorbance). The HPLC profiles of the esmT1, esmT2, and esmA3–A5mutants are similar to those of the LSB017 mutant
(B), and the profiles of the esmT3–T6, esmH2, and esmA6–A8 mutants highly resemble (C). The asterisk marks esmeraldic acid, which is heavily accumulated
upon prolonged culture of the wild-type strain and the LSB017 mutant carrying 3E11.
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Saphenamycin and Esmeraldin Biosynthesisincorporation of one malonyl extender unit. EsmB5 resembles
AnaA, a thioesterase that likely catalyzes the decarboxylative
chain release of the ACP-tethered polyketide to form anatoxin
in the cyanobacterium, Oscillatoria PCC 6506 (Me´jean et al.,
2009). EsmB3 displays modest homology to many acyl carrier
proteins (ACPs), suggesting a function in escorting the PDC
group for PKS condensation. All three esmB3–B5 mutants were
incapable of generating esmeraldin but accumulated PDC and
PCA (Figure 3), which confirmed their involvement in the conver-
sion of PDC to form the one-carbon-extended 6-acetyl-PCA.
Interestingly, the esmB1 and esmB2mutants displayed similar
metabolic profiles as the esmB3–B5 mutants (Figure 3) and
could not complement each other or the esmB3–B5 mutants
to produce esmeraldins. The gene pair esmB1/B2 is homolo-
gous to EhpF/GH and GriC/D involved in the assemblies of
D-alanylgriseolutate and grixazone in Erwinia herbicola and
Streptomyces griseus, respectively (Bera et al., 2010; Giddens
et al., 2002; Suzuki et al., 2007). As EhpF likely activates
the carboxylic group of PDC to an acyl-AMP intermediate in
D-alanylgriseolutate formation, EsmB1 could correspondingly
catalyze the adenylation of PDC. This priming step is analogous
to the common biosynthesis of aromatic starter-containing
polyketides (Ferreras et al., 2008; Rui et al., 2010). The catalytic
function of EsmB2 remains to be clarified.
Genetic complementation suggests that EsmC catalyzes the
ensuing reaction and provides substrate for the EsmD enzymes.
EsmC resembles AKR11A, a versatile aldo-keto reductase thatChemistry & Biology 19, 1116–112reduces glyceraldehyde, erythrose, 9,10-phenanthrenequinone,
and methylglyoxal in Bacillus subtilis (Ehrensberger and Wilson,
2004). As the green esmeraldin pigments were barely detectable
in the esmC mutant, which accumulated a large amount of
6-acetyl-PCA (Figure 3), EsmC likely reduces the acetyl group
of 6-acetyl-PCA to an alcohol moiety to give saphenic acid.
Notably, trace amounts of saphenamycin were observed by
liquid chromatography-tandem mass spectrometry (LC-MS),
suggesting that the EsmC function can be partially compensated
by a cellular keto reductase in the esmC mutant.
Esterification by the Atypical PKS EsmD1–D3
The results of previous feeding experiments implicate saphena-
mycin as the esterification product of a saphenic acid and a
6-methylsalicylic acid (6-MSA) (McDonald et al., 1999). No
related gene was clearly revealed in the cloned esm cluster.
Esmeraldin production was completely blocked in the esmD1
and esmD2 mutants, and considerably reduced in the esmD3
mutant. As all three esmD1–D3 mutants accumulated large
amounts of saphenic acid as shown by LC-MS analysis (Fig-
ure 3), EsmD1–D3 could function to convert saphenic acid to
saphenamycin.
EsmD1 displays homology with many b-ketoacyl-ACP syn-
thases, such as FabH and PqsD for the formation of fatty acids
and quinolones in E. coli and Pseudomonas, respectively (Bera
et al., 2009; Davies et al., 2000). Detailed sequence analysis
further revealed that EsmD1 is closely related to ChlB6, which5, September 21, 2012 ª2012 Elsevier Ltd All rights reserved 1119
Table 1. Deduced Functions of Open Reading Frames in the Esmeraldin Biosynthetic Gene Cluster and the Accumulated Phenazine
Metabolites Detected in the Corresponding Mutants
Protein AA Homolog (accession number) Identified or Proposed Function
Phenazine Metabolites Accumulated
by the Mutants
EsmA1 166 PhzA/B (PDB 3B4O) AOCHC dimerization PCA, saphenic acid, saphenamycin,
esmeraldins
EsmA2 211 PhzG (PDB 1TY9) PDC formation PCA, (PDC, saphenic acid, saphenamycin)a
EsmA3 245 PhzF (PDB 1U1W) DHHA isomerase None
EsmA4 222 PhzD (PDB 1NF8) DHHA synthase None
EsmA5 642 PhzE (Q51791.1) ADIC synthase None
EsmA6 471 Mt-DAH7PS (PDB 2B7O) DAHP synthase Similar to WT
EsmA7 394 MtCS (PDB 1ZTB) Chorismate synthase Similar to WT
EsmA8 178 AroK (PDB 2IYQ) Shikimate kinase Similar to WT
EsmB1 366 EphF (AAN40895) PDC adenylase PDC, PCA
EsmB2 413 EhpG/H (AAN40896/7) Function with EsmB1 PDC, PCA
EsmB3 135 SrfA-C PCP (PDB 2VSQ) Carrier protein PDC, PCA
EsmB4 924 JamP (AAS98787.1) KS-AT-ACP PDC, PCA
EsmB5 263 AnaA (ZP_07113992.1) Thioesterase PDC, PCA, (saphenamycin, esmeraldins)a
EsmC 357 Akr11a (PDB 1PYF) 6-acetyl-PCA reductase 6-acetyl-PCA, PDC, PCA, (saphenamycin)a
EsmD1 345 ChlB6 (AAZ77679.1) Esterification Saphenic acid, 6-acetyl-PCA, PCA
EsmD2 567 DhbE (PDB 1MDB) 6-MSA adenylase Saphenic acid, 6-acetyl-PCA, PCA
EsmD3 83 NSAS ACP (PDB 2KR5) 6-methylsalicylyl carrier protein Saphenic acid, 6-acetyl-PCA, PCA,
(esmeraldins)a
EsmT1 361 StrR (YP_001822413) Transcriptional activation None
EsmT2 931 LuxR (YP_001507857) Quorum sensing None
EsmT3 490 SAV_4476 (NP_825653.1) Integrin-like protein Similar to WT
EsmT4 242 CalR1 (AAM94766.1) Transcriptional regulation Similar to WT
EsmT5 350 Pur8 (spjP42670.1) Exporter Similar to WT
EsmT6 320 BenM (PDB 2H99) Transcriptional regulation Similar to WT
EsmH1 110 N/A Unknown Not available
EsmH2 145 Aln5 (ACI88872.1) Unknown Not available
PDB, Protein Data Bank ID code; WT, wild-type.
aBarely detectable accumulates.
Chemistry & Biology
Saphenamycin and Esmeraldin Biosynthesiscatalyzes the C-O bond formation between a 5-chloro-6-methyl-
O-methylsalicylyl-ACP and a deoxysugar to give chlorothricin in
S. antibioticus DSM 40725 (He et al., 2009). EsmD2 exhibits high
homology to many adenylases, such as DhbE and TsrA that acti-
vate aromatic carboxylates by adenylation and charge the aroyl
group to the dedicated carrier protein for the formations of poly-
peptides 2,3-dihydroxybenzoate and triostin, respectively (May
et al., 2002; Schmoock et al., 2005). We therefore propose that
EsmD2 adenylates 6-MSA to 6-methylsalicyl-AMP (6-MS-
AMP), which is subsequently loaded onto the acyl carrier protein
EsmD3 for the esterification with saphenic acid by EsmD1 to
afford saphenamycin. Unlike the esmD1 and esmD2 mutants,
a trace amount of green esmeraldin pigment was observed in
the esmD3mutant, implying that other carrier proteins, including
ACPs involved in primary fatty acid biosynthesis, may partially
contribute to residual esmeraldin biosynthesis.
The Regulation of the Esmeraldin Biosynthetic Pathway
In addition to the enzymes involved the structural assembly,
several potential regulatory enzymeswere revealed by sequence
analysis. EsmT1 exhibits high sequence identity with StrR,1120 Chemistry & Biology 19, 1116–1125, September 21, 2012 ª201a pathway-specific transcriptional activator that controls all
the streptomycin biosynthetic genes in Streptomyces griseus
(Tomono et al., 2005). As the nonpigmented esmT1mutant failed
to produce any phenazine metabolites, EsmT1 likely triggers the
esm genes for esmeraldin biosynthesis. As the esmT2 mutant
was also unable to generate phenazines, EsmT2, a tentative
LuxR-family transcription regulator, could serve in the upstream
quorum sensing system and govern the activation of EsmT1 in
the signal transduction cascade (Nasser and Reverchon, 2007).
EsmT4 and T6 are homologous to CalR1 and BenM, which
regulate the assembly of calicheamicin and degradation of
aromatic compounds in Micromonospora echinospora and
Acinetobacter baylyi, respectively (Ahlert et al., 2002; Craven
et al., 2009). The counterpart of these proteins could be
EsmT3, an integrin-like protein that senses environmental
signals and initiates the regulation. Furthermore, EsmT5 is
homologous to Pur8, implicated as an exporter of puromycin
metabolites in Streptomyces alboniger (Tercero et al., 1993).
EsmH1 and EsmH2 are two putative proteins with unknown
functions. As the esmT3–T6 mutants retain the production of
large amounts of esmeraldins in laboratory condition, suggesting2 Elsevier Ltd All rights reserved
P
D
C
  (
nm
ol
 / 
m
l)
P
C
A 
(n
m
ol
 / 
m
l)
P
he
na
zi
ne
 (n
m
ol
 / 
m
l)
0
5
10
15
20
25
30
0
50
100
150
200
250
300
350
0
5
10
15
20
25
Figure 4. Heterologous Expressions of PhzA-G, EsmA1, and EsmA2
in E. coli BL21 (DE3) pLysS
Bars represent amounts of PDC, PCA, and phenazine accumulated by E. coli
BL21 strains containing the corresponding genes (see Tables S3 and S4). Data
are averages from triplet cultures; error bars show SDs.
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Saphenamycin and Esmeraldin Biosynthesisthey do not play a role in esmeraldin biosynthesis but instead
form the boundaries of the esm cluster.
DISCUSSION
Saphenyl metabolites and esmeraldins represent the PDC-
derived phenazine products. In the esm gene cluster, PDC
assembly is governed by esmA1–A6 and two additional
esmA7–A8 that are not present in the other known phenazine
biosynthetic gene clusters (Mavrodi et al., 2010). As the
esmA3–A5mutants failed to produce any phenazine metabolite,
EsmA5–A3, homologs of the corresponding PhzD-F, are
required for the conversion of chorismic acid to give AOCHC
(Blankenfeldt et al., 2004; McDonald et al., 2001; Parsons
et al., 2003). AOCHC is further dimerized into hexahydro-PDC-
1either through a spontaneous reaction or by the catalytic
activity of EsmA1 (Figure 5).
The resulting hexahydro-PDC-1 can either undergo decarbox-
ylative dehydrogenations to form PCA and phenazine, or follow
three consecutive non-decarboxylative dehydrogenations to
give PDC (Figure 5). EsmA2 plays a crucial role in PDC assembly,
as the PDC-derived saphenyl metabolites were barely detect-
able in the esmA2 mutant, and the coexpression of EsmA2
with PhzC-F in E. coli enhanced the PDC production by 20-fold
compared with the strain expressing PhzC-F only. Moreover,
EsmA2 sustained a similar level of PCA and suppressed the yield
of the shunt product phenazine, which resembled the function of
PhzG. Since hexahydro-PDC-1 is oxygen sensitive and tends toChemistry & Biology 19, 1116–112be spontaneously decarboxylated to form PCA or phenazine
(Ahuja et al., 2008), we speculate that EsmA2 as well as PhzG
could shield the carboxylic groups of the nascent hexahydro-
PDC-1 by shifting 2,3-double bonds to the a-carbon position
to form hexahydro-PDC-2 (Ahuja et al., 2008). The detailed cata-
lytic mechanism of EsmA2 and other PhzG homologs remains to
be clarified.
Despite that the individual catalytic functions of EsmA1 and
EsmA2 are similar to those of PhzA/B and PhzG, respectively,
the synergistic activity of EsmA1/A2 is distinct from PhzAB/G.
In the presence of EsmA1/EsmA2/PhzC-F, the E. coli strain
accumulated 50-fold more PDC and 5-fold less PCA than
that expressing a full set of PhzA-G. This observation indi-
cates that EsmA1 and EsmA2 work together to direct the
biosynthetic flux toward PDC formation, and likely departed
from the evolutionary path of other PhzA/B and PhzG
orthologs that are committed to PCA productions in other
microorganisms. This assumption is reinforced by swapping
EsmA1 with PhzA/B or EsmA2 with PhzG, which considerably
decreased the PDC and PCA productions compared with
the strains presenting EsmA1/EsmA2/PhzC-F and PhzA-G,
respectively.
The mutation results indicate that EsmB1–B5 play key roles in
the one-carbon extension of PDC to form 6-acetyl-PCA. Likely,
EsmB1 adenylates and loads PDC onto the carrier protein
EsmB3, then the tethered PDC is condensed with a malonyl
unit by the type I polyketide synthase EsmB4 to give a
carboxyl-phenazine-ketoacyl-EsmB3 intermediate, which is
subsequently discharged by the thioesterase EsmB5 (Figure 5).
Since an anticipated b-keto acid intermediate, 6-carboxyacetyl-
PCA, was not detected in the esmC mutant, the release of the
b-keto acid is likely coupled with its decarboxylation to give
6-acetyl-PCA directly. Decarboxylation of 6-carboxyacetyl-
PCA could occur without enzyme participation, as b-keto acids
including the benzoyl acetic acids tend to lose the carboxylic
group spontaneously (Straub and Bender, 1972). However, this
possibility is ruled out by the demonstration that the appended
methyl group is formed stereospecifically from chiral acetate
(McDonald et al., 1999). Therefore, EsmB5 seems to engage in
decarboxylation, resembling the thioesterase CalE7 and the
polyketide synthase BAS, which catalyze both hydroxylation
and decarboxylation to release the polyketide products in
the biosynthesis of enediyne and benzalacetone, respectively
(Kotaka et al., 2009; Morita et al., 2010). Spontaneous decarbox-
ylation following discharge of the EsmB3-tethered 6-carboxya-
cetyl-PCA by other cellular thioesterases can account for the
observation that trace amounts of saphenamycin and esmeral-
dins were accumulated in the esmB5 mutant.
The function of EsmB2 remains to be clarified. Two homologs
of EsmB2, EhpG/H and GriD, were proposed to reduce the
carboxyl group to an aldehyde moiety in the biosynthesis
of D-alanylgriseolutate and grixazone, respectively (Giddens
et al., 2002; Suzuki et al., 2007). In contrast to EhpG/H and
GriD, the anticipated aldehyde intermediate, 6-formylphena-
zine-1-carboxylic acid (6-formyl-PCA), was not detected in the
esmB3–B5 mutant cultures. We speculate that EsmB2 may not
possess a catalytic activity but plays a critical structural role
assisting EsmB1 in loading PDC onto the EsmB3 carrier protein
in preparation for the subsequent polyketide extension.5, September 21, 2012 ª2012 Elsevier Ltd All rights reserved 1121
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Saphenamycin and Esmeraldin BiosynthesisDespite the sequence similarity between EsmD1 and
b-ketoacyl-ACP synthases, EsmD1 likely catalyzes the esterifi-
cation to attach the EsmD3-tethered 6-methylsalicyl group to
the hydroxyl group of saphenic acid (Figure 5). EsmD1 resem-
bles several esterification enzymes that use the ACP-tethered
acyl group as a substrate, including ChlB6, AviN, PokM2, and
PlaP2 involved in the formations of chlorothricin, avilamycin, pol-
yketomycin, and phenalinolactone, respectively (Daum et al.,
2009; Du¨rr et al., 2006; He et al., 2009; Weitnauer et al., 2001)
(Figure S3). Coincidently, these enzymes are all atypical PKSs,
analogous to NonJ/K that governs the ester bond formation in
nonactin biosynthesis (Kwon et al., 2002). As esterification only
differs from Claisen condensation in the nature of the nucleo-
phile, an alcohol versus an enolate anion, we speculate that
these atypical PKSs may represent a unique subfamily of ester-
ification enzymes that deviated from the evolutional expansion of
PKSs. It is worth mentioning that the cloned esm cluster does
not carry an iterative polyketide synthase gene accounting for
the assembly and release of 6-MSA (Moriguchi et al., 2010), in
contradistinction to the biosynthetic gene clusters of chlorothri-
cin and polyketomycin mentioned above (Daum et al., 2009; Jia
et al., 2006), which encode two 6-MSA synthases ChlB1 and
PokM1, respectively.
In view of the usual need for a carrier protein tethered acyl
substrate, saphenamycin biosynthesis likely employs EsmD2
to adenylate and load the free 6-MSA on EsmD3 to form
6-MS-EsmD3, resembling PlaP4, an adenylase-PCP (peptidyl
carrier protein)-fused protein that was proposed to activate
and tether the L-proline to the PCP domain for phenalinolactone
assembly (Du¨rr et al., 2006) (Figure S3). Distinct from the adeny-1122 Chemistry & Biology 19, 1116–1125, September 21, 2012 ª201lation strategy mentioned above, chlorothricin biosynthesis
employs a dedicated ChlB3 acyltransferase, which discharges
the 6-MS group from the 6-MSA synthase and delivers it to
ChlB2 ACP to form 6-MS-ACP (He et al., 2009). In addition,
the esterification enzymes, AviN and CalO4, were proposed to
act directly on the nascent orsellinyl group tethered to the
ACP domain of orsellinic acid synthase in the absence of any
adenylase or acyltransferase in the assembly of avilamycin
and calicheamicin, respectively (Ahlert et al., 2002; He et al.,
2009; Weitnauer et al., 2001). As the other saphenyl esters
contain various aliphatic acyl chains, which comprise the major
membrane fatty acid components in S. antibioticus, we specu-
late that EsmD1 can also recruit the FAS-ACP linked fatty acyl
intermediates to generate the corresponding saphenyl esters
and esmeraldin A compounds. This assumption is also sup-
ported by the fact that formation of a small amount of esmer-
aldins, likely esmeraldin A compounds, was retained in the
esmD3 mutant.
Saphenic acid was not dimerized into esmeraldic acid in the
esmD1 and esmD2 mutants, suggesting that the dimerization
reaction employs either saphemycin or other saphenyl ester
molecules. This result supports the previous feeding experiment
that labeled saphenic acid was unequally incorporated into the
two halves of esmeraldins (McDonald et al., 1999). As saphenic
acid can be converted to esmeraldins by all the esmA1–A8,
esmB1–B5, and esmC mutants in the genetic complementa-
tions, the involvement of EsmA-C enzymes was ruled out.
The anticipated genes engaged in the dimerization, 6-MSA
assembly, and self-immunity therefore must be located outside
the characterized esm cluster.2 Elsevier Ltd All rights reserved
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Saphenamycin and Esmeraldin BiosynthesisGiven that the high instability of the endogenous plasmid that
harbors the esm cluster, we exploited a cosmid-based trans-
poson mutagenesis strategy to effectively construct a series of
esm gene-disrupted mutants. The introduced kanamycin and
apramycin resistant genes, residing in the EZ-Tn5 transposon
and the pOJ446 cosmid vector, respectively, provide the selec-
tion markers to secure the presence of the targeted esm genes.
This approach can be applied to other unstable gene clusters,
which could be part of amobile element, a plasmid, or a telomeric
segment.
SIGNIFICANCE
This work revealed the key genes, esmA2 and A1, which are
in charge of the PDC formation. The identified PKS gene set,
esmB1–B5, has provided a unique biosynthetic model for
one-carbon extensions of various structural backbones.
The characterization of the atypical PKS, EsmD1–D3, estab-
lished an ACP/PCP-centered esterification strategy to
attach aromatic or fatty acid chains to the hydroxyethyl
moiety of the target compound. Phenazine metabolites ex-
hibit eminent bioactivities, but the application of these
compounds is hampered by low target specificity. The eluci-
dation of the biosynthetic pathways for saphenamycin and
esmeraldins paves the way for phenazine-metabolite bioen-
gineering, which could lead to the development of novel
bioactive compounds for the treatment of human diseases.
For example, saphenic acid, heavily accumulated by the
esmD1–D3mutants, can serve as a versatile pharmacophore
that could be tailored through chemical or biological syn-
thesis to render drug specificity. Besides, this study intro-
duces a cosmid-based transposon mutagenesis strategy,
which can be widely applied to study highly unstable gene
clusters.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions
S. antibioticus Tu¨ 2706 and E. coli strains were kindly provided by Dr. Hans
Za¨hner (Tu¨bingen, Germany) and the John Innes Center (Norwich, UK),
respectively. The S. antibioticus wild-type strain and mutants were grown at
30C in YMG medium (0.4% yeast extract, 1% malt extract, 0.4% glucose,
pH adjusted to 7.0) and MS medium (2% soybean meal and 2% D-mannitol)
for storage and fermentation, respectively. During the culture, green-pig-
mented colonies were selected for the wild-type strain. E. coli strains were
cultivated in Luria-Bertani medium at 37C. Chemical reagents and culture
medium ingredients were obtained from Sigma-Aldrich.
Construction and Screening of Genomic Library
The genomic DNA of S. antibioticus was extracted, partially digested with
Sau3AI, and ligated into pOJ446, an E. coli-Streptomyces shuttle vector.
The resulting mixture was packaged with the Gigapack III Gold Packaging
kit (Stratagene) and transfected into the E. coli SURE strain (Stratagene).
A 32P-labeled DNA probe, the insert region of pT7-6A-G carrying phzA-G,
was used for screening the constructed cosmid library.
DNA Manipulations and Mutagenesis
Standard molecular cloning procedures were carried out throughout this work.
The cosmids and plasmids were introduced into Streptomyces strains via
conjugation with E. coli ET12567/pUZ8002 (Kieser et al., 2000). Pulsed-field
gel electrophoresis and the genomic DNA preparation were carried out
following the described standard procedures (Kieser et al., 2000). The nativeChemistry & Biology 19, 1116–112or HpaI-digested genomic DNA was separated on a 1% agarose gel in
0.5 3 Tris-borate-EDTA buffer using 1 to 20 s pulses at 6V/cm and 14C
for 20 hr.
The EZ-Tn5 transposon mutants of 3E11 were generated following
the procedure provided by Epicenter Biotechnologies (Madison,WI). The posi-
tion and orientation of transposon insertion within 3E11 was mapped by
analyzing the fragments generated by restriction endonuclase digestion, and
then sequenced using transposon-specific primers. Sixty-three kanamycin-
resistant mutants were isolated and transposon insertions mapped within
the 30 kb esm cluster as outlined in Figure S2. Selected 3E11 mutants were
further introduced into LSB017 by interspecies conjugation with E. coli
ET12567/pUZ8002 to create transformants equivalent to the single-gene-
disrupted mutants.
For analysis of PCA/PDC production in E. coli, the regions of phzC-F and
phzA-F were PCR amplified from pT7-6A-G with pPhzC-F_F/R and pPhzA-
F_F/R and inserted in pET-30 Xa/LIC expression vector to give pZR17 and
pZR35, respectively (Table S2). esmA1 and esmA2 were cloned from 3E11
with pEsmA1_F/R and pEsmA2_F/R, and ligated into pRSETB expression
vector to give pZR26 and pZR18, respectively (Table S2). For coexpression
of EsmA1 and EsmA2, esmA2 with the T7 promoter from pZR18 was inserted
to the downstream of esmA1 in pZR26 to afford pZR28. The expression
constructs were (co-)transformed into E. coliBL21 (DE3) plysS cells by electro-
poration (Tables S2 and S3). The cells were grown in 25 ml of Luria-Bertani
medium containing 2.5 mM betaine and 1 M sorbitol medium with the cor-
responding antibiotics, chloramphenicol (25 mg/ml), ampicillin (100 mg/ml),
kanamycin (50 mg/ml), or apramycin (50 mg/ml) at 37C, induced at OD600
0.70–0.75 with 0.1 mM isopropyl b-D-1-thiogalactopyranoside at 28C, and
harvested after 22 hr. The analysis of phenazine metabolites by HPLC is
described as follows, except that the 80%–95% gradient step was omitted.
Phenazine Metabolite Analysis
The S. antibioticus wild-type strain or mutants were cultivated in 25 ml of MS
medium in baffled flasks with a coil at 250 rpm and 30C for 4–6 days. When
required, the culture medium was supplemented with apramycin and kana-
mycin at 50 and 25 mg/ml, respectively. One half milliliter of the fermented
cultures was acidified to pH 2.0 with 1N HCl and mixed thoroughly with an
equal volume of ethyl acetate. The mixture was separated by centrifugation,
and the ethyl acetate layer was collected, dried, and redissolved in 0.5 ml of
methanol. The crude extract was analyzed on a P680 HPLC system (Dionex,
Sunnyvale, CA) with an XTerra RP18 column (4.6 3 250 mm; Waters) at
a flow rate of 0.5 ml/min at 25C. Forty microliters of the crude extract was
injected, equilibrated with 45% solvent B (acetonitrile with 0.1% formic acid)
in solvent A (water with 0.1% formic acid) for 5 min, developed with a linear
gradient of 45%–60% solvent B in solvent A for 10 min, 80%–95% solvent B
in solvent A for another 10 min, and washed with 95% solvent B in solvent A
for 15 min. LC-MS analysis and high-resolution MS were performed on
a 6210-TOF LC-MS system (Agilent Technologies Inc., Santa Clara, CA) using
an XDB C18 column (4.63 250 mm; Agilent Technologies, Inc.) with the same
elution program as the HPLC analysis mentioned above. The exact masses of
the identified compounds are listed in Table S1.
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